TNF and psoriasis: Therefore, we applied WGCNA to coding genes and lncRNAs sequenced by RNA-seq on lesional skin samples from psoriasis patients before (PP) and after treatment (PT) with a TNF-α inhibitor, adalimumab, and on healthy control skin (NN).